Tomoyuki Kita
Overview
Explore the profile of Tomoyuki Kita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masakane I, Hanafusa N, Kita T, Maeda K
Contrib Nephrol
. 2016 Dec;
189:54-60.
PMID: 27951549
Background: Home hemodialysis (HHD) is rapidly becoming more widespread because HHD programs enable patients to receive a sufficient dialysis dose to improve their quality of life and survival rate without...
2.
Sasaki N, Yamashita T, Kasahara K, Fukunaga A, Yamaguchi T, Emoto T, et al.
Arterioscler Thromb Vasc Biol
. 2016 Oct;
37(1):66-74.
PMID: 27765767
Objective: UVB irradiation is an established treatment for immunoinflammatory cutaneous disorders and has been shown to suppress cutaneous and systemic inflammatory diseases through modulation of the adaptive immune response. However,...
3.
Masakane I, Hanafusa N, Kita T, Hasegawa T, Maeda K
Contrib Nephrol
. 2015 May;
185:32-41.
PMID: 26023013
Home hemodialysis (HHD) is one of the best choices for improving the quality of life and survival rate of dialysis patients because it can lead to longer and more frequent...
4.
Yashiro M, Kotera H, Matsukawa M, Kita T, Tanaka H, Sakai R
Int J Artif Organs
. 2015 Mar;
38(3):126-32.
PMID: 25744193
Purpose: Phosphorus removal is a major issue to assess for physicians engaging in hemodialysis. A pseudo-one-compartment model was reported as a novel model for phosphorus kinetics. We aimed to evaluate...
5.
Yodoi K, Yamashita T, Sasaki N, Kasahara K, Emoto T, Matsumoto T, et al.
Hypertension
. 2015 Jan;
65(4):889-95.
PMID: 25601931
Although regulatory T cells (Tregs) have been shown to play a protective role in abdominal aortic aneurysm (AAA) formation, it remains unclear whether expansion of endogenous Foxp3(+) Tregs prevents AAA....
6.
Kasahara K, Sasaki N, Yamashita T, Kita T, Yodoi K, Sasaki Y, et al.
J Am Heart Assoc
. 2014 Apr;
3(2):e000719.
PMID: 24755152
Background: Accumulating evidence suggests that the balance between pathogenic effector T cells (Teffs) and regulatory T cells (Tregs) may be important for controlling atherosclerotic disease. We hypothesized that a combination...
7.
Kita T, Yamashita T, Sasaki N, Kasahara K, Sasaki Y, Yodoi K, et al.
Cardiovasc Res
. 2014 Jan;
102(1):107-17.
PMID: 24403315
Aims: Although recent animal studies have investigated the cellular and molecular mechanisms underlying the process of atherosclerosis regression, it remains unknown whether adaptive immune responses including T cells are involved...
8.
Tanaka H, Sakai R, Kita T, Okamoto K, Mikami M
Contrib Nephrol
. 2012 May;
177:133-142.
PMID: 22613924
We started our home hemodialysis (HHD) program in July 2005 and have been promoting overnight HHD. As more than 6 years have passed since we started our HHD program, we...
9.
Nakajima K, Yamashita T, Kita T, Takeda M, Sasaki N, Kasahara K, et al.
Arterioscler Thromb Vasc Biol
. 2011 Aug;
31(9):1963-72.
PMID: 21817104
Objective: Eicosapentaenoic acid (EPA) has been shown to have beneficial effects on cardiovascular diseases, although the precise mechanism is unknown. We investigated the effect of EPA on the regression of...
10.
Goto S, Yoshiya K, Kita T, Fujii H, Fukagawa M
Ther Apher Dial
. 2011 Mar;
15(2):132-4.
PMID: 21426503
Uremic toxins are associated with various disorders in patients with end-stage renal disease and it is difficult to remove some of these toxins by dialysis. Since some uremic toxins are...